0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Osteoarthritis Medications Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-28E5704
Home | Market Reports | Health | Health Conditions | Arthritis
Global Osteoarthritis Medications Market Insights Forecast to 2028

Global Osteoarthritis Medications Market Insights, Forecast to 2028

Code: QYRE-Auto-28E5704
Report
February 2022
128 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Osteoarthritis is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint. This report mainly studies the Drugs for Osteoarthritis market, the key role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Osteoarthritis Medications Market Statistics 2028

The global Osteoarthritis Medications market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, NSAIDs accounting for % of the Osteoarthritis Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.

China Osteoarthritis Medications market size is valued at US$ million in 2021, while the North America and Europe Osteoarthritis Medications are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Osteoarthritis Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osteoarthritis Medications market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osteoarthritis Medications market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osteoarthritis Medications market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osteoarthritis Medications market.

Osteoarthritis Medications Market Size

Osteoarthritis Medications market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • NSAIDs
  • Corticosteroids
  • Hyaluronic Acid Injection
  • Others

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

BY COMPANY

  • Pfizer
  • Johnson & Johnson
  • GlaxoSmithKline
  • Novartis
  • Bayer
  • Eli Lilly
  • Sanofi
  • Horizon Pharma
  • Abbott
  • Mylan
  • Daiichi Sankyo
  • TEVA
  • Almatica Pharma
  • Astellas Pharma
  • Tide Pharmaceutical
  • Iroko Pharmaceuticals
  • Hengrui Pharmaceutical
  • Abiogen Pharma
  • Flexion Therapeutics
  • Anika Therapeutics

BY REGION

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoarthritis Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Hyaluronic Acid Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Osteoarthritis Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Medications Market Perspective (2017-2028)
2.2 Osteoarthritis Medications Growth Trends by Region
2.2.1 Osteoarthritis Medications Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Osteoarthritis Medications Historic Market Size by Region (2017-2022)
2.2.3 Osteoarthritis Medications Forecasted Market Size by Region (2023-2028)
2.3 Osteoarthritis Medications Market Dynamics
2.3.1 Osteoarthritis Medications Industry Trends
2.3.2 Osteoarthritis Medications Market Drivers
2.3.3 Osteoarthritis Medications Market Challenges
2.3.4 Osteoarthritis Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteoarthritis Medications Players by Revenue
3.1.1 Global Top Osteoarthritis Medications Players by Revenue (2017-2022)
3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2017-2022)
3.2 Global Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Osteoarthritis Medications Revenue
3.4 Global Osteoarthritis Medications Market Concentration Ratio
3.4.1 Global Osteoarthritis Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Medications Revenue in 2021
3.5 Osteoarthritis Medications Key Players Head office and Area Served
3.6 Key Players Osteoarthritis Medications Product Solution and Service
3.7 Date of Enter into Osteoarthritis Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoarthritis Medications Breakdown Data by Type
4.1 Global Osteoarthritis Medications Historic Market Size by Type (2017-2022)
4.2 Global Osteoarthritis Medications Forecasted Market Size by Type (2023-2028)
5 Osteoarthritis Medications Breakdown Data by Application
5.1 Global Osteoarthritis Medications Historic Market Size by Application (2017-2022)
5.2 Global Osteoarthritis Medications Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Osteoarthritis Medications Market Size (2017-2028)
6.2 North America Osteoarthritis Medications Market Size by Type
6.2.1 North America Osteoarthritis Medications Market Size by Type (2017-2022)
6.2.2 North America Osteoarthritis Medications Market Size by Type (2023-2028)
6.2.3 North America Osteoarthritis Medications Market Share by Type (2017-2028)
6.3 North America Osteoarthritis Medications Market Size by Application
6.3.1 North America Osteoarthritis Medications Market Size by Application (2017-2022)
6.3.2 North America Osteoarthritis Medications Market Size by Application (2023-2028)
6.3.3 North America Osteoarthritis Medications Market Share by Application (2017-2028)
6.4 North America Osteoarthritis Medications Market Size by Country
6.4.1 North America Osteoarthritis Medications Market Size by Country (2017-2022)
6.4.2 North America Osteoarthritis Medications Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Osteoarthritis Medications Market Size (2017-2028)
7.2 Europe Osteoarthritis Medications Market Size by Type
7.2.1 Europe Osteoarthritis Medications Market Size by Type (2017-2022)
7.2.2 Europe Osteoarthritis Medications Market Size by Type (2023-2028)
7.2.3 Europe Osteoarthritis Medications Market Share by Type (2017-2028)
7.3 Europe Osteoarthritis Medications Market Size by Application
7.3.1 Europe Osteoarthritis Medications Market Size by Application (2017-2022)
7.3.2 Europe Osteoarthritis Medications Market Size by Application (2023-2028)
7.3.3 Europe Osteoarthritis Medications Market Share by Application (2017-2028)
7.4 Europe Osteoarthritis Medications Market Size by Country
7.4.1 Europe Osteoarthritis Medications Market Size by Country (2017-2022)
7.4.2 Europe Osteoarthritis Medications Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Medications Market Size (2017-2028)
8.2 Asia-Pacific Osteoarthritis Medications Market Size by Type
8.2.1 Asia-Pacific Osteoarthritis Medications Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Osteoarthritis Medications Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Osteoarthritis Medications Market Share by Type (2017-2028)
8.3 Asia-Pacific Osteoarthritis Medications Market Size by Application
8.3.1 Asia-Pacific Osteoarthritis Medications Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Osteoarthritis Medications Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Osteoarthritis Medications Market Share by Application (2017-2028)
8.4 Asia-Pacific Osteoarthritis Medications Market Size by Region
8.4.1 Asia-Pacific Osteoarthritis Medications Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Osteoarthritis Medications Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Osteoarthritis Medications Market Size (2017-2028)
9.2 Latin America Osteoarthritis Medications Market Size by Type
9.2.1 Latin America Osteoarthritis Medications Market Size by Type (2017-2022)
9.2.2 Latin America Osteoarthritis Medications Market Size by Type (2023-2028)
9.2.3 Latin America Osteoarthritis Medications Market Share by Type (2017-2028)
9.3 Latin America Osteoarthritis Medications Market Size by Application
9.3.1 Latin America Osteoarthritis Medications Market Size by Application (2017-2022)
9.3.2 Latin America Osteoarthritis Medications Market Size by Application (2023-2028)
9.3.3 Latin America Osteoarthritis Medications Market Share by Application (2017-2028)
9.4 Latin America Osteoarthritis Medications Market Size by Country
9.4.1 Latin America Osteoarthritis Medications Market Size by Country (2017-2022)
9.4.2 Latin America Osteoarthritis Medications Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteoarthritis Medications Market Size (2017-2028)
10.2 Middle East & Africa Osteoarthritis Medications Market Size by Type
10.2.1 Middle East & Africa Osteoarthritis Medications Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Osteoarthritis Medications Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Osteoarthritis Medications Market Share by Type (2017-2028)
10.3 Middle East & Africa Osteoarthritis Medications Market Size by Application
10.3.1 Middle East & Africa Osteoarthritis Medications Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Osteoarthritis Medications Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Osteoarthritis Medications Market Share by Application (2017-2028)
10.4 Middle East & Africa Osteoarthritis Medications Market Size by Country
10.4.1 Middle East & Africa Osteoarthritis Medications Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Osteoarthritis Medications Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Osteoarthritis Medications Introduction
11.1.4 Pfizer Revenue in Osteoarthritis Medications Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Osteoarthritis Medications Introduction
11.2.4 Johnson & Johnson Revenue in Osteoarthritis Medications Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Osteoarthritis Medications Introduction
11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Osteoarthritis Medications Introduction
11.4.4 Novartis Revenue in Osteoarthritis Medications Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Osteoarthritis Medications Introduction
11.5.4 Bayer Revenue in Osteoarthritis Medications Business (2017-2022)
11.5.5 Bayer Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Osteoarthritis Medications Introduction
11.6.4 Eli Lilly Revenue in Osteoarthritis Medications Business (2017-2022)
11.6.5 Eli Lilly Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Osteoarthritis Medications Introduction
11.7.4 Sanofi Revenue in Osteoarthritis Medications Business (2017-2022)
11.7.5 Sanofi Recent Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Osteoarthritis Medications Introduction
11.8.4 Horizon Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
11.8.5 Horizon Pharma Recent Developments
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Osteoarthritis Medications Introduction
11.9.4 Abbott Revenue in Osteoarthritis Medications Business (2017-2022)
11.9.5 Abbott Recent Developments
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Osteoarthritis Medications Introduction
11.10.4 Mylan Revenue in Osteoarthritis Medications Business (2017-2022)
11.10.5 Mylan Recent Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Osteoarthritis Medications Introduction
11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2017-2022)
11.11.5 Daiichi Sankyo Recent Developments
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Osteoarthritis Medications Introduction
11.12.4 TEVA Revenue in Osteoarthritis Medications Business (2017-2022)
11.12.5 TEVA Recent Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Osteoarthritis Medications Introduction
11.13.4 Almatica Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
11.13.5 Almatica Pharma Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Osteoarthritis Medications Introduction
11.14.4 Astellas Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
11.14.5 Astellas Pharma Recent Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Osteoarthritis Medications Introduction
11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022)
11.15.5 Tide Pharmaceutical Recent Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2017-2022)
11.16.5 Iroko Pharmaceuticals Recent Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022)
11.17.5 Hengrui Pharmaceutical Recent Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Osteoarthritis Medications Introduction
11.18.4 Abiogen Pharma Revenue in Osteoarthritis Medications Business (2017-2022)
11.18.5 Abiogen Pharma Recent Developments
11.19 Flexion Therapeutics
11.19.1 Flexion Therapeutics Company Details
11.19.2 Flexion Therapeutics Business Overview
11.19.3 Flexion Therapeutics Osteoarthritis Medications Introduction
11.19.4 Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022)
11.19.5 Flexion Therapeutics Recent Developments
11.20 Anika Therapeutics
11.20.1 Anika Therapeutics Company Details
11.20.2 Anika Therapeutics Business Overview
11.20.3 Anika Therapeutics Osteoarthritis Medications Introduction
11.20.4 Anika Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022)
11.20.5 Anika Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Osteoarthritis Medications Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of NSAIDs
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Hyaluronic Acid Injection
    Table 5. Key Players of Others
    Table 6. Global Osteoarthritis Medications Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Osteoarthritis Medications Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Osteoarthritis Medications Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Osteoarthritis Medications Market Share by Region (2017-2022)
    Table 10. Global Osteoarthritis Medications Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Osteoarthritis Medications Market Share by Region (2023-2028)
    Table 12. Osteoarthritis Medications Market Trends
    Table 13. Osteoarthritis Medications Market Drivers
    Table 14. Osteoarthritis Medications Market Challenges
    Table 15. Osteoarthritis Medications Market Restraints
    Table 16. Global Osteoarthritis Medications Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Osteoarthritis Medications Revenue Share by Players (2017-2022)
    Table 18. Global Top Osteoarthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2021)
    Table 19. Ranking of Global Top Osteoarthritis Medications Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Osteoarthritis Medications Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Osteoarthritis Medications Product Solution and Service
    Table 23. Date of Enter into Osteoarthritis Medications Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Osteoarthritis Medications Revenue Market Share by Type (2017-2022)
    Table 27. Global Osteoarthritis Medications Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Osteoarthritis Medications Revenue Market Share by Type (2023-2028)
    Table 29. Global Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Osteoarthritis Medications Revenue Share by Application (2017-2022)
    Table 31. Global Osteoarthritis Medications Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Osteoarthritis Medications Revenue Share by Application (2023-2028)
    Table 33. North America Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Osteoarthritis Medications Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Osteoarthritis Medications Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Osteoarthritis Medications Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Osteoarthritis Medications Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Osteoarthritis Medications Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Osteoarthritis Medications Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Osteoarthritis Medications Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Osteoarthritis Medications Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Osteoarthritis Medications Product
    Table 66. Pfizer Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. Johnson & Johnson Company Details
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Osteoarthritis Medications Product
    Table 71. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 72. Johnson & Johnson Recent Developments
    Table 73. GlaxoSmithKline Company Details
    Table 74. GlaxoSmithKline Business Overview
    Table 75. GlaxoSmithKline Osteoarthritis Medications Product
    Table 76. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 77. GlaxoSmithKline Recent Developments
    Table 78. Novartis Company Details
    Table 79. Novartis Business Overview
    Table 80. Novartis Osteoarthritis Medications Product
    Table 81. Novartis Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 82. Novartis Recent Developments
    Table 83. Bayer Company Details
    Table 84. Bayer Business Overview
    Table 85. Bayer Osteoarthritis Medications Product
    Table 86. Bayer Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 87. Bayer Recent Developments
    Table 88. Eli Lilly Company Details
    Table 89. Eli Lilly Business Overview
    Table 90. Eli Lilly Osteoarthritis Medications Product
    Table 91. Eli Lilly Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 92. Eli Lilly Recent Developments
    Table 93. Sanofi Company Details
    Table 94. Sanofi Business Overview
    Table 95. Sanofi Osteoarthritis Medications Product
    Table 96. Sanofi Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 97. Sanofi Recent Developments
    Table 98. Horizon Pharma Company Details
    Table 99. Horizon Pharma Business Overview
    Table 100. Horizon Pharma Osteoarthritis Medications Product
    Table 101. Horizon Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 102. Horizon Pharma Recent Developments
    Table 103. Abbott Company Details
    Table 104. Abbott Business Overview
    Table 105. Abbott Osteoarthritis Medications Product
    Table 106. Abbott Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 107. Abbott Recent Developments
    Table 108. Mylan Company Details
    Table 109. Mylan Business Overview
    Table 110. Mylan Osteoarthritis Medications Product
    Table 111. Mylan Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 112. Mylan Recent Developments
    Table 113. Daiichi Sankyo Company Details
    Table 114. Daiichi Sankyo Business Overview
    Table 115. Daiichi Sankyo Osteoarthritis Medications Product
    Table 116. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 117. Daiichi Sankyo Recent Developments
    Table 118. TEVA Company Details
    Table 119. TEVA Business Overview
    Table 120. TEVA Osteoarthritis Medications Product
    Table 121. TEVA Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 122. TEVA Recent Developments
    Table 123. Almatica Pharma Company Details
    Table 124. Almatica Pharma Business Overview
    Table 125. Almatica Pharma Osteoarthritis Medications Product
    Table 126. Almatica Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 127. Almatica Pharma Recent Developments
    Table 128. Astellas Pharma Company Details
    Table 129. Astellas Pharma Business Overview
    Table 130. Astellas Pharma Osteoarthritis Medications Product
    Table 131. Astellas Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 132. Astellas Pharma Recent Developments
    Table 133. Tide Pharmaceutical Company Details
    Table 134. Tide Pharmaceutical Business Overview
    Table 135. Tide Pharmaceutical Osteoarthritis Medications Product
    Table 136. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 137. Tide Pharmaceutical Recent Developments
    Table 138. Iroko Pharmaceuticals Company Details
    Table 139. Iroko Pharmaceuticals Business Overview
    Table 140. Iroko Pharmaceuticals Osteoarthritis Medications Product
    Table 141. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 142. Iroko Pharmaceuticals Recent Developments
    Table 143. Hengrui Pharmaceutical Company Details
    Table 144. Hengrui Pharmaceutical Business Overview
    Table 145. Hengrui Pharmaceutical Osteoarthritis Medications Product
    Table 146. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 147. Hengrui Pharmaceutical Recent Developments
    Table 148. Abiogen Pharma Company Details
    Table 149. Abiogen Pharma Business Overview
    Table 150. Abiogen Pharma Osteoarthritis Medications Product
    Table 151. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 152. Abiogen Pharma Recent Developments
    Table 153. Flexion Therapeutics Company Details
    Table 154. Flexion Therapeutics Business Overview
    Table 155. Flexion Therapeutics Osteoarthritis Medications Product
    Table 156. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 157. Flexion Therapeutics Recent Developments
    Table 158. Anika Therapeutics Company Details
    Table 159. Anika Therapeutics Business Overview
    Table 160. Anika Therapeutics Osteoarthritis Medications Product
    Table 161. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2017-2022) & (US$ Million)
    Table 162. Anika Therapeutics Recent Developments
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Osteoarthritis Medications Market Share by Type: 2021 VS 2028
    Figure 2. NSAIDs Features
    Figure 3. Corticosteroids Features
    Figure 4. Hyaluronic Acid Injection Features
    Figure 5. Others Features
    Figure 6. Global Osteoarthritis Medications Market Share by Application: 2021 VS 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Osteoarthritis Medications Report Years Considered
    Figure 11. Global Osteoarthritis Medications Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Osteoarthritis Medications Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Osteoarthritis Medications Market Share by Region: 2021 VS 2028
    Figure 14. Global Osteoarthritis Medications Market Share by Players in 2021
    Figure 15. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Osteoarthritis Medications Revenue in 2021
    Figure 17. North America Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 19. North America Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 20. North America Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 21. United States Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 27. Germany Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Osteoarthritis Medications Market Size Share by Region (2017-2028)
    Figure 37. China Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 47. Mexico Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Osteoarthritis Medications Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Osteoarthritis Medications Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Osteoarthritis Medications Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Osteoarthritis Medications Market Size Share by Country (2017-2028)
    Figure 53. Turkey Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Osteoarthritis Medications Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 61. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 62. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 63. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 64. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 65. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 66. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 67. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 68. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 69. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 70. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 71. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 72. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 73. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 74. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 75. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global Gout Therapeutics Market Size Status and Forecast 2021 2027
Global Gout Therapeutics Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-10L6185
Sun Aug 07 00:00:00 UTC 2022

Add to Cart

Global Rheumatoid Arthritis Testing Market Research Report 2022
Global Rheumatoid Arthritis Testing Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-33E11182
Wed Jul 13 00:00:00 UTC 2022

Add to Cart

Global Rheumatoid Arthritis Medicine Market Research Report 2022
Global Rheumatoid Arthritis Medicine Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-27I11141
Tue Jul 12 00:00:00 UTC 2022

Add to Cart

Global Seropositive Rheumatoid Arthritis Drug Market Research Report 2022
Global Seropositive Rheumatoid Arthritis Drug Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-20P11313
Tue Jul 12 00:00:00 UTC 2022

Add to Cart